Mitsubishi UFJ Trust & Banking Corp Has $2.03 Million Stock Holdings in Tenet Healthcare Co. (NYSE:THC)

Mitsubishi UFJ Trust & Banking Corp decreased its stake in Tenet Healthcare Co. (NYSE:THCGet Rating) by 19.6% in the 2nd quarter, Holdings Channel.com reports. The firm owned 38,572 shares of the company’s stock after selling 9,388 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp’s holdings in Tenet Healthcare were worth $2,027,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Washington Trust Advisors Inc. bought a new position in shares of Tenet Healthcare during the first quarter valued at $34,000. Parkside Financial Bank & Trust raised its stake in shares of Tenet Healthcare by 1,063.9% during the first quarter. Parkside Financial Bank & Trust now owns 419 shares of the company’s stock valued at $36,000 after acquiring an additional 383 shares during the last quarter. Lazard Asset Management LLC bought a new position in shares of Tenet Healthcare during the first quarter valued at $36,000. Prospera Financial Services Inc bought a new position in shares of Tenet Healthcare during the first quarter valued at $73,000. Finally, Point72 Hong Kong Ltd bought a new position in shares of Tenet Healthcare during the first quarter valued at $78,000. Institutional investors own 97.38% of the company’s stock.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, CFO Daniel J. Cancelmi bought 11,000 shares of Tenet Healthcare stock in a transaction dated Wednesday, October 26th. The shares were purchased at an average cost of $43.07 per share, with a total value of $473,770.00. Following the transaction, the chief financial officer now directly owns 392,815 shares of the company’s stock, valued at $16,918,542.05. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 1.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on THC. Raymond James lowered their target price on shares of Tenet Healthcare from $135.00 to $80.00 and set a “strong-buy” rating for the company in a research note on Thursday, October 27th. Mizuho lowered their target price on shares of Tenet Healthcare from $80.00 to $60.00 and set a “buy” rating for the company in a research note on Wednesday, November 2nd. Citigroup lowered their target price on shares of Tenet Healthcare from $99.00 to $76.00 and set a “buy” rating for the company in a research note on Tuesday, October 25th. Barclays reduced their price target on shares of Tenet Healthcare from $104.00 to $67.00 and set an “overweight” rating for the company in a report on Monday, October 24th. Finally, UBS Group reduced their price target on shares of Tenet Healthcare from $113.00 to $91.00 and set a “buy” rating for the company in a report on Thursday, July 28th. Two research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $72.38.

Tenet Healthcare Stock Up 6.5 %

THC opened at $45.11 on Friday. The company has a debt-to-equity ratio of 5.97, a current ratio of 1.40 and a quick ratio of 1.31. The company’s 50-day moving average is $49.66 and its 200 day moving average is $57.49. Tenet Healthcare Co. has a fifty-two week low of $36.69 and a fifty-two week high of $92.65. The firm has a market capitalization of $4.88 billion, a P/E ratio of 8.88, a PEG ratio of 1.17 and a beta of 2.24.

Tenet Healthcare (NYSE:THCGet Rating) last announced its quarterly earnings data on Friday, October 21st. The company reported $1.44 EPS for the quarter, topping the consensus estimate of $1.28 by $0.16. Tenet Healthcare had a net margin of 2.93% and a return on equity of 38.12%. The business had revenue of $4.80 billion for the quarter, compared to analyst estimates of $4.80 billion. During the same quarter in the previous year, the firm posted $1.99 earnings per share. The company’s revenue for the quarter was down 1.9% on a year-over-year basis. Research analysts expect that Tenet Healthcare Co. will post 6.14 earnings per share for the current fiscal year.

Tenet Healthcare announced that its board has authorized a share buyback program on Thursday, October 20th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase up to 22.4% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s board of directors believes its shares are undervalued.

About Tenet Healthcare

(Get Rating)

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

See Also

Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Co. (NYSE:THCGet Rating).

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.